4-aminopyridine has been researched along with Hypertrophy, Left Ventricular in 2 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shipsey, SJ | 1 |
| Bryant, SM | 1 |
| Hart, G | 1 |
| Gillis, AM | 1 |
| Geonzon, RA | 1 |
| Mathison, HJ | 1 |
| Kulisz, E | 1 |
| Lester, WM | 1 |
| Duff, HJ | 1 |
2 other studies available for 4-aminopyridine and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Effects of hypertrophy on regional action potential characteristics in the rat left ventricle: a cellular basis for T-wave inversion?
Topics: 4-Aminopyridine; Action Potentials; Animals; Cell Membrane; Chelating Agents; Disease Models, Animal | 1997 |
The effects of barium, dofetilide and 4-aminopyridine (4-AP) on ventricular repolarization in normal and hypertrophied rabbit heart.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Barium; Electrocardiography; Heart; Hypertrophy, L | 1998 |